Form 8-K - Current report:
SEC Accession No. 0000950170-25-036819
Filing Date
2025-03-11
Accepted
2025-03-11 07:03:36
Documents
13
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qttb-20250311.htm   iXBRL 8-K 42939
2 EX-99.1 qttb-ex99_1.htm EX-99.1 210112
3 GRAPHIC img38152436_0.jpg GRAPHIC 43680
  Complete submission text file 0000950170-25-036819.txt   440164

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20250311.xsd EX-101.SCH 25023
15 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20250311_htm.xml XML 4727
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 25725826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)